174 related articles for article (PubMed ID: 13319594)
1. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
LANDY M; PILLEMER L
J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
[TBL] [Abstract][Full Text] [Related]
2. Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.
LANDY M; PILLEMER L
J Exp Med; 1956 Sep; 104(3):383-409. PubMed ID: 13357692
[TBL] [Abstract][Full Text] [Related]
3. The properdin system and immunity. VII. Alterations in properdin levels and resistance to infection in mice following the administration of tissue polysaccharides.
PILLEMER L; LANDY M; SHEAR MJ
J Exp Med; 1957 Jul; 106(1):99-110. PubMed ID: 13439118
[TBL] [Abstract][Full Text] [Related]
4. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
HERBUT PA; KRAEMER WH
Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
[No Abstract] [Full Text] [Related]
5. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
LEON MA
J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
[TBL] [Abstract][Full Text] [Related]
6. The properdin system and immunity. III. The zymosan assay of properdin.
PILLEMER L; BLUM L; LEPOW IH; WURZ L; TODD EW
J Exp Med; 1956 Jan; 103(1):1-13. PubMed ID: 13278451
[TBL] [Abstract][Full Text] [Related]
7. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
HINZ CF; WEDGWOOD RJ; PILLEMER L
J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
[No Abstract] [Full Text] [Related]
8. Quantitative studies on the properdin-complement system.
LEON MA
J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
[TBL] [Abstract][Full Text] [Related]
9. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
ANDREEVA ZM; NIKITINA VD
Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
[No Abstract] [Full Text] [Related]
10. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
SZABO IK
Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
[No Abstract] [Full Text] [Related]
11. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
HOOK WA; CAREY WF; MUSCHEL LH
J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
[No Abstract] [Full Text] [Related]
12. [Immuno-electrophoretic studies on properdin-zymosan and properdin-inulin complex; an analysis of electrophoretic and immunologic behavior of properdin].
SCHEIFFARTH F; FRENGER W; GOTZ H
Klin Wochenschr; 1958 Apr; 36(8):367-9. PubMed ID: 13550834
[No Abstract] [Full Text] [Related]
13. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
FUMAROLA D; MODICA F
Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
[No Abstract] [Full Text] [Related]
14. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.
PILLEMER L; SCHOENBERG MD; BLUM L; WURZ L
Science; 1955 Sep; 122(3169):545-9. PubMed ID: 13255887
[No Abstract] [Full Text] [Related]
15. A NEW METHOD FOR THE STUDY OF CYTOTOXIC SYSTEMS (SPECIFIC EVEN NON-SPECIFIC) OF BLOOD SERUMS.
RYBAK M; PETAKOVA M; SIMONIANOVA E
Z Immunitats Allergieforsch; 1963 Oct; 125():351-7. PubMed ID: 14117569
[No Abstract] [Full Text] [Related]
16. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
ZSEBOK Z; WACHTL I; SZY S; SELLEI G
Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
[No Abstract] [Full Text] [Related]
17. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
[No Abstract] [Full Text] [Related]
18. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
BLUM L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
[No Abstract] [Full Text] [Related]
19. [On the problem of the method of determination of properdin in human serum by the zymosan method].
MASHKOV AV; MIKHAILOVA ZM
Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
[No Abstract] [Full Text] [Related]
20. Anaphylactic shock in zymosan pre-treated guinea-pigs. (A study on the possible role of properdin)].
WILHELM RE; SALVAGGIO J; KRUPP I
Int Arch Allergy Appl Immunol; 1961; 18():318-29. PubMed ID: 13831364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
